Back to

Chris Llewellyn

Senior Partner, London
Leads our digital and analytics work in the life sciences and healthcare spaces globally

About Chris

A surgeon by background, Chris has extensive knowledge and experience in healthcare. He leads McKinsey's digital and artificial intelligence (AI) work in healthcare and life sciences, having previously led McKinsey's medtech work and been a leader in the global Pharmaceuticals & Medical Products Practice.

Since joining in 2004, Chris has partnered with executives and leaders across the healthcare sector—working with health systems, payors, providers, pharmaceutical companies, medical device manufacturers, and private equity. His work focuses on transforming company performance, including reshaping strategy, defining and implementing novel commercial approaches, refining the operating model, transforming the cost base, improving product development, and finding new sources of growth.

Today Chris leads a team of data scientists, data engineers, software engineers, designers (physical and digital), and digital business builders deploying AI and digital approaches to disrupt the business system, and has successfully applied this to multiple different contexts.

An occasional advisor to national governments, Chris also helps guide large-scale public investments in the life sciences. He has worked with the President of Israel to plan a world-leading neurotechnology cluster, and he helped the UK Prime Minister develop a national life sciences strategy, focused on attracting investment and boosting employment in the sector and beyond.

He is a frequent speaker at industry association meetings and conferences.

Before McKinsey, Chris worked as a surgeon in the UK National Health Service and taught at Imperial College, London.

Published work

Solutions and services in medical devices: White space or white elephants?,” McKinsey & Company, June 2019

The European public-procurement opportunity: Delivering value in medtech,” McKinsey & Company, December 2018

Improving healthcare while curbing cost: Med-tech companies offer a solution,” McKinsey & Company, October 2015

Capturing the new 'value' segment in medical devices,” McKinsey & Company, January 2015


Imperial College London
MBBS (with distinction), surgery and medicine

University of Oxford
MA (with honors), physiological sciences